1. Home
  2. UNFI vs DVAX Comparison

UNFI vs DVAX Comparison

Compare UNFI & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United Natural Foods Inc.

UNFI

United Natural Foods Inc.

HOLD

Current Price

$34.30

Market Cap

2.0B

ML Signal

HOLD

Logo Dynavax Technologies Corporation

DVAX

Dynavax Technologies Corporation

HOLD

Current Price

$15.67

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNFI
DVAX
Founded
1976
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Food Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
1996
2004

Fundamental Metrics

Financial Performance
Metric
UNFI
DVAX
Price
$34.30
$15.67
Analyst Decision
Hold
Hold
Analyst Count
8
5
Target Price
$37.13
$26.50
AVG Volume (30 Days)
896.5K
5.7M
Earning Date
03-10-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$31,753,000,000.00
$330,514,000.00
Revenue This Year
$2.45
$24.63
Revenue Next Year
$2.14
$15.85
P/E Ratio
N/A
N/A
Revenue Growth
1.45
26.73
52 Week Low
$20.78
$9.20
52 Week High
$43.29
$15.73

Technical Indicators

Market Signals
Indicator
UNFI
DVAX
Relative Strength Index (RSI) 51.41 85.69
Support Level $32.06 $15.57
Resistance Level $35.25 $15.69
Average True Range (ATR) 1.20 0.07
MACD 0.21 -0.09
Stochastic Oscillator 70.53 83.33

Price Performance

Historical Comparison
UNFI
DVAX

About UNFI United Natural Foods Inc.

United Natural Foods Inc is a wholesale distributor of natural, organic and specialty foods and nonfood products across North America. The company's products consist of national, regional and private label brands grouped into grocery and general merchandise, produce, perishables and frozen foods, nutritional supplements and sports nutrition, bulk and foodservice products, and personal care items. United Natural Foods serves various retail formats including conventional supermarket chains, natural product superstores, independent retail operators and foodservice channels such as e-commerce platforms. The company's operations are comprised of principal divisions: the wholesale division; the retail division; and other.

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: